Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Verani

Showing results (171-180 of 259) with videos related to

Pageof 26
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2023
Stunting Following Moderate-to-Severe Diarrhea Among Children Aged <5 Years in Africa Before and After Rotavirus Vaccine Introduction: A Comparison of the Global Enteric Multicenter Study and the Vaccine Impact on Diarrhea in Africa (VIDA) StudyDilruba Nasrin, Yuanyuan Liang, Jennifer R Verani, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.
BMC Pregnancy and Childbirth|February 12, 2024
Risk factors of adverse birth outcomes among a cohort of pregnant women in Coastal Kenya, 2017-2019Harriet Mirieri, Ruth Nduati, Jeanette Dawa, et al.
MMWR. Morbidity and Mortality Weekly Report|May 5, 2022
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022Namrata Prasad, Gordana Derado, Srinivas Acharya Nanduri, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2009
Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infectionJennifer R Verani, Amy Seitz, Robert H Gilman, et al.
The Lancet. Global Health|June 18, 2021
Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studiesNaor Bar-Zeev, Todd D Swarthout, Dean B Everett, et al.
MMWR. Morbidity and Mortality Weekly Report|March 18, 2021
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021Amadea Britton, Kara M Jacobs Slifka, Chris Edens, et al.
MMWR. Morbidity and Mortality Weekly Report|August 26, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021Srinivas Nanduri, Tamara Pilishvili, Gordana Derado, et al.
Plos One|October 11, 2019
Pathogen surveillance in the informal settlement, Kibera, Kenya, using a metagenomics approachRene S Hendriksen, Oksana Lukjancenko, Patrick Munk, et al.
Plos One|August 1, 2024
Acute febrile illness in Kenya: Clinical characteristics and pathogens detected among patients hospitalized with fever, 2017-2019Jennifer R Verani, Eric Ng' Eno, Elizabeth A Hunsperger, et al.
Pageof 26

Showing results (171-180 of 259) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2023
Stunting Following Moderate-to-Severe Diarrhea Among Children Aged <5 Years in Africa Before and After Rotavirus Vaccine Introduction: A Comparison of the Global Enteric Multicenter Study and the Vaccine Impact on Diarrhea in Africa (VIDA) StudyDilruba Nasrin, Yuanyuan Liang, Jennifer R Verani, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.
BMC Pregnancy and Childbirth|February 12, 2024
Risk factors of adverse birth outcomes among a cohort of pregnant women in Coastal Kenya, 2017-2019Harriet Mirieri, Ruth Nduati, Jeanette Dawa, et al.
MMWR. Morbidity and Mortality Weekly Report|May 5, 2022
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022Namrata Prasad, Gordana Derado, Srinivas Acharya Nanduri, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2009
Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infectionJennifer R Verani, Amy Seitz, Robert H Gilman, et al.
The Lancet. Global Health|June 18, 2021
Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006-18: prospective observational time-series and case-control studiesNaor Bar-Zeev, Todd D Swarthout, Dean B Everett, et al.
MMWR. Morbidity and Mortality Weekly Report|March 18, 2021
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021Amadea Britton, Kara M Jacobs Slifka, Chris Edens, et al.
MMWR. Morbidity and Mortality Weekly Report|August 26, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021Srinivas Nanduri, Tamara Pilishvili, Gordana Derado, et al.
Plos One|October 11, 2019
Pathogen surveillance in the informal settlement, Kibera, Kenya, using a metagenomics approachRene S Hendriksen, Oksana Lukjancenko, Patrick Munk, et al.
Plos One|August 1, 2024
Acute febrile illness in Kenya: Clinical characteristics and pathogens detected among patients hospitalized with fever, 2017-2019Jennifer R Verani, Eric Ng' Eno, Elizabeth A Hunsperger, et al.
Pageof 26